542 related articles for article (PubMed ID: 33479198)
1. The SARS-CoV-2 nucleocapsid phosphoprotein forms mutually exclusive condensates with RNA and the membrane-associated M protein.
Lu S; Ye Q; Singh D; Cao Y; Diedrich JK; Yates JR; Villa E; Cleveland DW; Corbett KD
Nat Commun; 2021 Jan; 12(1):502. PubMed ID: 33479198
[TBL] [Abstract][Full Text] [Related]
2. The SARS-CoV-2 Nucleocapsid phosphoprotein forms mutually exclusive condensates with RNA and the membrane-associated M protein.
Lu S; Ye Q; Singh D; Villa E; Cleveland DW; Corbett KD
bioRxiv; 2020 Jul; ():. PubMed ID: 32766587
[TBL] [Abstract][Full Text] [Related]
3. Genomics-guided targeting of stress granule proteins G3BP1/2 to inhibit SARS-CoV-2 propagation.
Ali N; Prasad K; AlAsmari AF; Alharbi M; Rashid S; Kumar V
Int J Biol Macromol; 2021 Nov; 190():636-648. PubMed ID: 34517025
[TBL] [Abstract][Full Text] [Related]
4. Phosphoregulation of Phase Separation by the SARS-CoV-2 N Protein Suggests a Biophysical Basis for its Dual Functions.
Carlson CR; Asfaha JB; Ghent CM; Howard CJ; Hartooni N; Safari M; Frankel AD; Morgan DO
Mol Cell; 2020 Dec; 80(6):1092-1103.e4. PubMed ID: 33248025
[TBL] [Abstract][Full Text] [Related]
5. SARS-CoV-2 N Protein Antagonizes Stress Granule Assembly and IFN Production by Interacting with G3BPs to Facilitate Viral Replication.
Liu H; Bai Y; Zhang X; Gao T; Liu Y; Li E; Wang X; Cao Z; Zhu L; Dong Q; Hu Y; Wang G; Song C; Niu X; Zheng T; Wang D; Liu Z; Jin Y; Li P; Bian X; Cao C; Liu X
J Virol; 2022 Jun; 96(12):e0041222. PubMed ID: 35652658
[TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2 nucleocapsid protein forms condensates with viral genomic RNA.
Jack A; Ferro LS; Trnka MJ; Wehri E; Nadgir A; Nguyenla X; Fox D; Costa K; Stanley S; Schaletzky J; Yildiz A
PLoS Biol; 2021 Oct; 19(10):e3001425. PubMed ID: 34634033
[TBL] [Abstract][Full Text] [Related]
7. SARS-CoV-2 NSP5 and N protein counteract the RIG-I signaling pathway by suppressing the formation of stress granules.
Zheng Y; Deng J; Han L; Zhuang MW; Xu Y; Zhang J; Nan ML; Xiao Y; Zhan P; Liu X; Gao C; Wang PH
Signal Transduct Target Ther; 2022 Jan; 7(1):22. PubMed ID: 35075101
[TBL] [Abstract][Full Text] [Related]
8. Nsp1 proteins of human coronaviruses HCoV-OC43 and SARS-CoV2 inhibit stress granule formation.
Dolliver SM; Kleer M; Bui-Marinos MP; Ying S; Corcoran JA; Khaperskyy DA
PLoS Pathog; 2022 Dec; 18(12):e1011041. PubMed ID: 36534661
[TBL] [Abstract][Full Text] [Related]
9. Genomic RNA Elements Drive Phase Separation of the SARS-CoV-2 Nucleocapsid.
Iserman C; Roden CA; Boerneke MA; Sealfon RSG; McLaughlin GA; Jungreis I; Fritch EJ; Hou YJ; Ekena J; Weidmann CA; Theesfeld CL; Kellis M; Troyanskaya OG; Baric RS; Sheahan TP; Weeks KM; Gladfelter AS
Mol Cell; 2020 Dec; 80(6):1078-1091.e6. PubMed ID: 33290746
[TBL] [Abstract][Full Text] [Related]
10. SARS-CoV-2 nucleocapsid protein interacts with immunoregulators and stress granules and phase separates to form liquid droplets.
Somasekharan SP; Gleave M
FEBS Lett; 2021 Dec; 595(23):2872-2896. PubMed ID: 34780058
[TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2 nucleocapsid protein phase-separates with RNA and with human hnRNPs.
Perdikari TM; Murthy AC; Ryan VH; Watters S; Naik MT; Fawzi NL
EMBO J; 2020 Dec; 39(24):e106478. PubMed ID: 33200826
[TBL] [Abstract][Full Text] [Related]
12. Interaction between host G3BP and viral nucleocapsid protein regulates SARS-CoV-2 replication and pathogenicity.
Yang Z; Johnson BA; Meliopoulos VA; Ju X; Zhang P; Hughes MP; Wu J; Koreski KP; Clary JE; Chang TC; Wu G; Hixon J; Duffner J; Wong K; Lemieux R; Lokugamage KG; Alvarado RE; Crocquet-Valdes PA; Walker DH; Plante KS; Plante JA; Weaver SC; Kim HJ; Meyers R; Schultz-Cherry S; Ding Q; Menachery VD; Taylor JP
Cell Rep; 2024 Mar; 43(3):113965. PubMed ID: 38492217
[TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2 Nucleocapsid Protein Targets a Conserved Surface Groove of the NTF2-like Domain of G3BP1.
Biswal M; Lu J; Song J
J Mol Biol; 2022 May; 434(9):167516. PubMed ID: 35240128
[TBL] [Abstract][Full Text] [Related]
14. The SARS-CoV-2 nucleocapsid protein is dynamic, disordered, and phase separates with RNA.
Cubuk J; Alston JJ; Incicco JJ; Singh S; Stuchell-Brereton MD; Ward MD; Zimmerman MI; Vithani N; Griffith D; Wagoner JA; Bowman GR; Hall KB; Soranno A; Holehouse AS
Nat Commun; 2021 Mar; 12(1):1936. PubMed ID: 33782395
[TBL] [Abstract][Full Text] [Related]
15. ATP biphasically modulates LLPS of SARS-CoV-2 nucleocapsid protein and specifically binds its RNA-binding domain.
Dang M; Li Y; Song J
Biochem Biophys Res Commun; 2021 Feb; 541():50-55. PubMed ID: 33477032
[TBL] [Abstract][Full Text] [Related]
16. SARS-CoV-2 structural coverage map reveals viral protein assembly, mimicry, and hijacking mechanisms.
O'Donoghue SI; Schafferhans A; Sikta N; Stolte C; Kaur S; Ho BK; Anderson S; Procter JB; Dallago C; Bordin N; Adcock M; Rost B
Mol Syst Biol; 2021 Sep; 17(9):e10079. PubMed ID: 34519429
[TBL] [Abstract][Full Text] [Related]
17. Separate domains of G3BP promote efficient clustering of alphavirus replication complexes and recruitment of the translation initiation machinery.
Götte B; Panas MD; Hellström K; Liu L; Samreen B; Larsson O; Ahola T; McInerney GM
PLoS Pathog; 2019 Jun; 15(6):e1007842. PubMed ID: 31199850
[TBL] [Abstract][Full Text] [Related]
18. Proteomic analysis identifies the RNA helicase DDX3X as a host target against SARS-CoV-2 infection.
Ciccosanti F; Di Rienzo M; Romagnoli A; Colavita F; Refolo G; Castilletti C; Agrati C; Brai A; Manetti F; Botta L; Capobianchi MR; Ippolito G; Piacentini M; Fimia GM
Antiviral Res; 2021 Jun; 190():105064. PubMed ID: 33781803
[TBL] [Abstract][Full Text] [Related]
19. Arginine methylation of SARS-Cov-2 nucleocapsid protein regulates RNA binding, its ability to suppress stress granule formation, and viral replication.
Cai T; Yu Z; Wang Z; Liang C; Richard S
J Biol Chem; 2021 Jul; 297(1):100821. PubMed ID: 34029587
[TBL] [Abstract][Full Text] [Related]
20. The stress granule protein G3BP1 binds viral dsRNA and RIG-I to enhance interferon-β response.
Kim SS; Sze L; Liu C; Lam KP
J Biol Chem; 2019 Apr; 294(16):6430-6438. PubMed ID: 30804210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
